{"id":27865,"date":"2025-11-03T17:23:19","date_gmt":"2025-11-04T00:23:19","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/?p=27865"},"modified":"2025-11-03T17:23:22","modified_gmt":"2025-11-04T00:23:22","slug":"ivig-for-parvovirus-b19-induced-pure-red-cell-aplasia-benefits-success-rates-and-treatment-insights","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-parvovirus-b19-induced-pure-red-cell-aplasia-benefits-success-rates-and-treatment-insights\/","title":{"rendered":"Inmunoglobulina intravenosa (IVIG) para la aplasia eritroide pura inducida por parvovirus B19: beneficios, tasas de \u00e9xito y perspectivas de tratamiento"},"content":{"rendered":"\n<p><a href=\"https:\/\/ameripharmaspecialty.com\/ivig\/ivig\/\">IVIG<\/a> for parvovirus B19-induced pure red cell aplasia is often considered the first-line treatment, especially in individuals with weakened immune systems. Learn about the benefits of IVIG, mechanism of action, and limitations of use.\u00a0<\/p>\n\n\n\n<div  id=\"call-to-action-649c1c0fab4415db6c878f01d6df3478\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tThe Best IVIG Home Infusion\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-parvovirus-b19-induced-pure-red-cell-aplasia-benefits-success-rates-and-treatment-insights\/#A_Quick_Overview\" >A Quick Overview<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-parvovirus-b19-induced-pure-red-cell-aplasia-benefits-success-rates-and-treatment-insights\/#What_Are_the_Benefits_of_IVIG_for_Parvovirus_B19-Induced_Pure_Red_Cell_Aplasia\" >What Are the Benefits of IVIG for Parvovirus B19-Induced Pure Red Cell Aplasia?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-parvovirus-b19-induced-pure-red-cell-aplasia-benefits-success-rates-and-treatment-insights\/#Whats_the_Success_Rate_of_IVIG_for_Parvovirus_B19-Induced_Pure_Red_Cell_Aplasia\" >What\u2019s the Success Rate of IVIG for Parvovirus B19-Induced Pure Red Cell Aplasia?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-parvovirus-b19-induced-pure-red-cell-aplasia-benefits-success-rates-and-treatment-insights\/#IVIG_for_Parvovirus_B19-Induced_Pure_Red_Cell_Aplasia_How_Does_IVIG_Work\" >IVIG for Parvovirus B19-Induced Pure Red Cell Aplasia: How Does IVIG Work?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-parvovirus-b19-induced-pure-red-cell-aplasia-benefits-success-rates-and-treatment-insights\/#Limitations_of_IVIG\" >Limitations of IVIG<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-parvovirus-b19-induced-pure-red-cell-aplasia-benefits-success-rates-and-treatment-insights\/#What_To_Expect_During_IVIG\" >What To Expect During IVIG<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-parvovirus-b19-induced-pure-red-cell-aplasia-benefits-success-rates-and-treatment-insights\/#Frequently_Asked_Questions\" >Frequently Asked Questions<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"A_Quick_Overview\"><\/span>A Quick Overview <span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Pure red cell aplasia is a rare condition. It occurs when cells that eventually turn into red blood cells become depleted or absent in the bone marrow. As a result, the bone marrow fails to produce sufficient healthy red blood cells, leading to severe anemia. Symptoms can include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Shortness of breath\u00a0<\/li>\n\n\n\n<li>Weakness\u00a0<\/li>\n\n\n\n<li>Dizziness<\/li>\n\n\n\n<li>Fatigue<\/li>\n<\/ul>\n\n\n\n<p>Parvovirus B19-induced pure red cell aplasia occurs when severe anemia develops following infection with parvovirus B19.&nbsp;<\/p>\n\n\n\n<p>In otherwise healthy individuals, anemia is transient and often self-limiting. However, anemia can last longer and may cause life-threatening complications in immunocompromised individuals such as those with HIV\/AIDS or transplant recipients.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Are_the_Benefits_of_IVIG_for_Parvovirus_B19-Induced_Pure_Red_Cell_Aplasia\"><\/span>What Are the Benefits of IVIG for Parvovirus B19-Induced Pure Red Cell Aplasia?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>IVIG is often considered the primary treatment for parvovirus B19-induced pure red cell aplasia in individuals with weakened immune systems [<a href=\"https:\/\/www.criteria.blood.gov.au\/MedicalCondition\/View\/2520\">1<\/a>,<a href=\"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/21\/6451\/497485\/Treatment-strategy-for-acquired-pure-red-cell\">2<\/a>].<\/p>\n\n\n\n<p>Several case reports suggest IVIG for parvovirus B19-induced pure red cell aplasia may cure or correct anemia within weeks.<\/p>\n\n\n\n<p>For example, in a 2022 study, researchers from Norway reported a case of a 39-year-old man who had successfully received a pancreas from a donor. The person was receiving immunosuppressive drugs to prevent the rejection of the transplanted organ.&nbsp;<\/p>\n\n\n\n<p>Several months after the transplant, the person was diagnosed with parvovirus B19-induced pure red cell aplasia. Following the diagnosis, the person received 30 g (0.4 g\/kg\/day) IVIG for 6 consecutive days. At the end of the IVIG therapy, hemoglobin levels gradually increased to a satisfactory level [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8966125\/#\">3<\/a>].&nbsp;<\/p>\n\n\n\n<p>Nonetheless, relapses occurred at 4 and 8 months after IVIG therapy. On both occasions, IVIG was administered with promising results.&nbsp;<\/p>\n\n\n\n<p>Another 2022 review analyzed data of eight kidney and two heart transplant patients and 86 studies to determine the use of IVIG and recurrence rate. All cases in the study had parvovirus B19-induced pure red cell aplasia and were solid organ recipients.&nbsp;<\/p>\n\n\n\n<p>The researcher found that [<a href=\"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S1246782021005309\">4<\/a>]:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>About 91% of cases received IVIG<\/li>\n\n\n\n<li>About 54% received IVIG and immunosuppression reduction<\/li>\n\n\n\n<li>6.5% of cases showed reduced immunosuppression without IVIG<\/li>\n\n\n\n<li>Recurrence rate was 17.5%<\/li>\n<\/ul>\n\n\n\n<p>They also noted that reducing the use of immunosuppressive medicines may help resolve anemia in individuals with parvovirus.&nbsp;<\/p>\n\n\n\n<p>In a 2024 study, two kidney transplant recipients with relapsing parvovirus B19-induced pure red cell aplasia were treated with 0.4g\/kg\/day of IVIG and a reduced amount of immunosuppressive medication. Although they relapsed around the same time frame as other patients, they responded to treatment earlier, showing some success for this dosing regimen [<a href=\"https:\/\/www.ectrx.org\/forms\/ectrxcontentshow.php?year=2024&amp;volume=22&amp;issue=1&amp;supplement=0&amp;makale_no=0&amp;spage_number=75&amp;content_type=FULL%20TEXT\">5<\/a>].<\/p>\n\n\n\n<div  id=\"call-to-action-3b2f4779462d37881d5c4f033fb3ee38\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tConsult an IVIG Specialist\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"#form\">Schedule Now<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Whats_the_Success_Rate_of_IVIG_for_Parvovirus_B19-Induced_Pure_Red_Cell_Aplasia\"><\/span>What\u2019s the Success Rate of IVIG for Parvovirus B19-Induced Pure Red Cell Aplasia?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"420\" height=\"321\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-home.jpg\" alt=\"Patient receiving IVIG treatment at home\" class=\"wp-image-27870\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-home.jpg 420w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-home-300x229.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-home-16x12.jpg 16w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-home-86x66.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-home-167x128.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-home-280x214.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-home-370x283.jpg 370w\" sizes=\"auto, (max-width: 420px) 100vw, 420px\" \/><\/figure>\n<\/div>\n\n\n<ul class=\"wp-block-list\">\n<li>Viral load<\/li>\n\n\n\n<li>Type of organ transplant\u00a0<\/li>\n\n\n\n<li>Underlying health conditions of the patient<\/li>\n\n\n\n<li>Type and dosage of immunosuppressive agent taken by the patient\u00a0<\/li>\n<\/ul>\n\n\n\n<p>Success rate may vary depending on several factors, including:<\/p>\n\n\n\n<p>According to a review published in <em>Clinical Infectious Diseases<\/em>, 93% of study participants achieved satisfactory hemoglobin levels after the first IVIG therapy. Unfortunately, relapse occurred in about 40% of participants after about 130 days [<a href=\"https:\/\/academic.oup.com\/cid\/article-abstract\/56\/7\/968\/359513?redirectedFrom=fulltext\">6<\/a>].&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"IVIG_for_Parvovirus_B19-Induced_Pure_Red_Cell_Aplasia_How_Does_IVIG_Work\"><\/span>IVIG for Parvovirus B19-Induced Pure Red Cell Aplasia: How Does IVIG Work?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Individuals with weakened immune systems do not have enough proteins (<a href=\"https:\/\/ameripharmaspecialty.com\/ivig\/immunoglobulins-ig\/\">antibodies<\/a>) against parvovirus B19. IVIG contains significant amounts of these antibodies, which neutralize parvovirus B19 and help correct anemia.&nbsp;<\/p>\n\n\n\n<p>Nonetheless, relapses can occur when there are insufficient virus-neutralizing antibodies, which is common with IVIG treatment discontinuation.&nbsp;<\/p>\n\n\n\n<p>Yet, IVIG remains the treatment of choice, given that no specific antiviral drug against parvovirus exists, and case reports suggest most patients respond to IVIG.&nbsp;&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Limitations_of_IVIG\"><\/span>Limitations of IVIG <span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Despite widespread use, IVIG for parvovirus B19-induced pure red cell aplasia faces several challenges, such as:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>A lack of optimal dosage and duration of IVIG therapy from large, controlled trials\u00a0<\/li>\n\n\n\n<li>IVIG may not be necessary for all HIV patients who have parvovirus B19-induced pure red cell aplasia [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10368220\/\">7<\/a>]<\/li>\n\n\n\n<li>IVIG treatment does not always eradicate parvovirus B19, and relapses may occur (requiring repeated IVIG administration)<\/li>\n\n\n\n<li>A lack of cost-benefit comparison between low- and high-dose IVIG<\/li>\n\n\n\n<li>IVIG availability and rising costs, especially with repeated administration<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_To_Expect_During_IVIG\"><\/span>What To Expect During IVIG<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>You will receive IVIG as a slow infusion into your veins (intravenous) at an infusion center or at home. Though IVIG is generally safe and well-tolerated, you may experience side effects, typically during the first 60 minutes of infusion, such as:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Shortness of breath<\/li>\n\n\n\n<li>Wheezing<\/li>\n\n\n\n<li>Chest tightness<\/li>\n\n\n\n<li>Coughing<\/li>\n\n\n\n<li>Headache<\/li>\n\n\n\n<li>Nausea<\/li>\n\n\n\n<li>Vomiting\u00a0<\/li>\n\n\n\n<li>Fever Rash\u00a0<\/li>\n\n\n\n<li>Back pain\u00a0<\/li>\n<\/ul>\n\n\n\n<p>To minimize the risk of such reactions, your healthcare provider may give you fluids and <a href=\"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-premedication-essential-things-to-know\/\">IVIG premedications<\/a>.&nbsp;<\/p>\n\n\n\n<div  id=\"call-to-action-7a1837d28ca7ab58b89a886ec48312d9\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tGet IVIG Copay Assistance\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span>Frequently Asked Questions<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h4 class=\"wp-block-heading\">How does IVIG work for parvovirus B19-induced pure red cell aplasia?<\/h4>\n\n\n\n<p>IVIG works for parvovirus B19-induced pure red cell aplasia by providing virus-neutralizing antibodies to the patient. There has also been evidence to suggest IVIG therapy can promote antibody formation in affected patients [<a href=\"https:\/\/www.cureus.com\/articles\/63973-exploring-the-rare-etiology-of-severe-anemia-in-an-immunocompromised-patient#!\/\">8<\/a>].<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">What is the treatment for parvovirus B19?<\/h4>\n\n\n\n<p>Standard parvovirus B19 infections are generally mild and self-limiting. Complete recovery occurs in most individuals who are otherwise healthy. Treatment may involve medications to relieve fever, itching, and joint pain and swelling.&nbsp;<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">How do you treat aplastic anemia due to parvovirus?<\/h4>\n\n\n\n<p>The most preferred treatment for parvovirus-associated severe aplastic anemia is bone marrow transplantation.&nbsp;<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">How does parvovirus B19 cause pure red cell aplasia?<\/h4>\n\n\n\n<p>Parvovirus B19 specifically targets and destroys cells that would otherwise mature into red blood cells. Consequently, the bone marrow is unable to produce mature red blood cells, leading to a dramatic drop in hemoglobin levels.&nbsp;<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">What drugs cause pure red cell aplasia?<\/h4>\n\n\n\n<p>The three drugs most commonly associated with pure red cell aplasia are:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Phenytoin (anticonvulsant)<\/li>\n\n\n\n<li>Azathioprine (immunosuppressive agent)<\/li>\n\n\n\n<li>Isoniazid (antibiotic to treat tuberculosis)<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>La inmunoglobulina intravenosa (IGIV) para la aplasia eritroide pura inducida por parvovirus B19 se considera a menudo el tratamiento de primera l\u00ednea, especialmente en personas inmunocomprometidas. Conozca los beneficios, el mecanismo de acci\u00f3n y las limitaciones de uso de la IGIV.\u00a0<\/p>","protected":false},"author":27,"featured_media":27866,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[7],"tags":[33],"class_list":["post-27865","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ivig","tag-dr-samantha-kaeberlein"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>IVIG for Parvovirus B19-Induced Pure Red Cell Aplasia: Benefits, Success Rates, and Treatment Insights - AmeriPharma\u00ae Specialty Care<\/title>\n<meta name=\"description\" content=\"Learn about IVIG for parvovirus B19-induced pure red cell aplasia. We discuss benefits of IVIG, mechanism of action, and limitations of use.\u00a0\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IVIG for Parvovirus B19-Induced Pure Red Cell Aplasia: Benefits, Success Rates, and Treatment Insights - AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"og:description\" content=\"Learn about IVIG for parvovirus B19-induced pure red cell aplasia. We discuss benefits of IVIG, mechanism of action, and limitations of use.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-parvovirus-b19-induced-pure-red-cell-aplasia-benefits-success-rates-and-treatment-insights\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-04T00:23:19+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-04T00:23:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/IVIG-Parvovirus.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Samantha Kaeberlein, PharmD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Samantha Kaeberlein, PharmD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-parvovirus-b19-induced-pure-red-cell-aplasia-benefits-success-rates-and-treatment-insights\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-parvovirus-b19-induced-pure-red-cell-aplasia-benefits-success-rates-and-treatment-insights\\\/\"},\"author\":{\"name\":\"Dr. Samantha Kaeberlein, PharmD\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/person\\\/aa941bb470287e10309b2fe7f5b15430\"},\"headline\":\"IVIG for Parvovirus B19-Induced Pure Red Cell Aplasia: Benefits, Success Rates, and Treatment Insights\",\"datePublished\":\"2025-11-04T00:23:19+00:00\",\"dateModified\":\"2025-11-04T00:23:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-parvovirus-b19-induced-pure-red-cell-aplasia-benefits-success-rates-and-treatment-insights\\\/\"},\"wordCount\":973,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-parvovirus-b19-induced-pure-red-cell-aplasia-benefits-success-rates-and-treatment-insights\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/IVIG-Parvovirus.jpg\",\"keywords\":[\"Dr. Samantha Kaeberlein\"],\"articleSection\":[\"IVIG\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-parvovirus-b19-induced-pure-red-cell-aplasia-benefits-success-rates-and-treatment-insights\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-parvovirus-b19-induced-pure-red-cell-aplasia-benefits-success-rates-and-treatment-insights\\\/\",\"name\":\"IVIG for Parvovirus B19-Induced Pure Red Cell Aplasia: Benefits, Success Rates, and Treatment Insights - AmeriPharma\u00ae Specialty Care\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-parvovirus-b19-induced-pure-red-cell-aplasia-benefits-success-rates-and-treatment-insights\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-parvovirus-b19-induced-pure-red-cell-aplasia-benefits-success-rates-and-treatment-insights\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/IVIG-Parvovirus.jpg\",\"datePublished\":\"2025-11-04T00:23:19+00:00\",\"dateModified\":\"2025-11-04T00:23:22+00:00\",\"description\":\"Learn about IVIG for parvovirus B19-induced pure red cell aplasia. We discuss benefits of IVIG, mechanism of action, and limitations of use.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-parvovirus-b19-induced-pure-red-cell-aplasia-benefits-success-rates-and-treatment-insights\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-parvovirus-b19-induced-pure-red-cell-aplasia-benefits-success-rates-and-treatment-insights\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-parvovirus-b19-induced-pure-red-cell-aplasia-benefits-success-rates-and-treatment-insights\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/IVIG-Parvovirus.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/IVIG-Parvovirus.jpg\",\"width\":1280,\"height\":853,\"caption\":\"Nurse preparing patient for IVIG for Parvovirus B19-Induced Pure Red Cell Aplasia\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-parvovirus-b19-induced-pure-red-cell-aplasia-benefits-success-rates-and-treatment-insights\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IVIG for Parvovirus B19-Induced Pure Red Cell Aplasia: Benefits, Success Rates, and Treatment Insights\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/person\\\/aa941bb470287e10309b2fe7f5b15430\",\"name\":\"Dr. Samantha Kaeberlein, PharmD\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fabe5720eac93901a4790d5e25493a8cf2fdf076c21466237b10de4cc181b9d2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fabe5720eac93901a4790d5e25493a8cf2fdf076c21466237b10de4cc181b9d2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fabe5720eac93901a4790d5e25493a8cf2fdf076c21466237b10de4cc181b9d2?s=96&d=mm&r=g\",\"caption\":\"Dr. Samantha Kaeberlein, PharmD\"},\"description\":\"Dr. Samantha Kaeberlein, PharmD was born and raised in Canton, OH. She received her pharmacy degree from Northeast Ohio Medical University (NEOMED) in 2020. The most rewarding part of her job is providing medical guidance so patients can make informed, well-rounded decisions regarding their healthcare. Her areas of expertise are geriatrics and long-term care. In her free time, she enjoys spending time outdoors, reading, and hunting for the best cup of coffee in America.\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/author\\\/samantha\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Inmunoglobulina intravenosa para la aplasia pura de gl\u00f3bulos rojos inducida por parvovirus B19: beneficios, tasas de \u00e9xito y perspectivas del tratamiento - AmeriPharma\u00ae Specialty Care","description":"Aprenda sobre la inmunoglobulina intravenosa (IVIG) para la aplasia pura de gl\u00f3bulos rojos inducida por parvovirus B19. Analizamos los beneficios de la IVIG, su mecanismo de acci\u00f3n y sus limitaciones de uso.\u00a0","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"es_MX","og_type":"article","og_title":"IVIG for Parvovirus B19-Induced Pure Red Cell Aplasia: Benefits, Success Rates, and Treatment Insights - AmeriPharma\u00ae Specialty Care","og_description":"Learn about IVIG for parvovirus B19-induced pure red cell aplasia. We discuss benefits of IVIG, mechanism of action, and limitations of use.\u00a0","og_url":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-parvovirus-b19-induced-pure-red-cell-aplasia-benefits-success-rates-and-treatment-insights\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2025-11-04T00:23:19+00:00","article_modified_time":"2025-11-04T00:23:22+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/IVIG-Parvovirus.jpg","type":"image\/jpeg"}],"author":"Dr. Samantha Kaeberlein, PharmD","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Samantha Kaeberlein, PharmD","Est. reading time":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-parvovirus-b19-induced-pure-red-cell-aplasia-benefits-success-rates-and-treatment-insights\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-parvovirus-b19-induced-pure-red-cell-aplasia-benefits-success-rates-and-treatment-insights\/"},"author":{"name":"Dr. Samantha Kaeberlein, PharmD","@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/person\/aa941bb470287e10309b2fe7f5b15430"},"headline":"IVIG for Parvovirus B19-Induced Pure Red Cell Aplasia: Benefits, Success Rates, and Treatment Insights","datePublished":"2025-11-04T00:23:19+00:00","dateModified":"2025-11-04T00:23:22+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-parvovirus-b19-induced-pure-red-cell-aplasia-benefits-success-rates-and-treatment-insights\/"},"wordCount":973,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-parvovirus-b19-induced-pure-red-cell-aplasia-benefits-success-rates-and-treatment-insights\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/IVIG-Parvovirus.jpg","keywords":["Dr. Samantha Kaeberlein"],"articleSection":["IVIG"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-parvovirus-b19-induced-pure-red-cell-aplasia-benefits-success-rates-and-treatment-insights\/","url":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-parvovirus-b19-induced-pure-red-cell-aplasia-benefits-success-rates-and-treatment-insights\/","name":"Inmunoglobulina intravenosa para la aplasia pura de gl\u00f3bulos rojos inducida por parvovirus B19: beneficios, tasas de \u00e9xito y perspectivas del tratamiento - AmeriPharma\u00ae Specialty Care","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-parvovirus-b19-induced-pure-red-cell-aplasia-benefits-success-rates-and-treatment-insights\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-parvovirus-b19-induced-pure-red-cell-aplasia-benefits-success-rates-and-treatment-insights\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/IVIG-Parvovirus.jpg","datePublished":"2025-11-04T00:23:19+00:00","dateModified":"2025-11-04T00:23:22+00:00","description":"Aprenda sobre la inmunoglobulina intravenosa (IVIG) para la aplasia pura de gl\u00f3bulos rojos inducida por parvovirus B19. Analizamos los beneficios de la IVIG, su mecanismo de acci\u00f3n y sus limitaciones de uso.\u00a0","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-parvovirus-b19-induced-pure-red-cell-aplasia-benefits-success-rates-and-treatment-insights\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-parvovirus-b19-induced-pure-red-cell-aplasia-benefits-success-rates-and-treatment-insights\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-parvovirus-b19-induced-pure-red-cell-aplasia-benefits-success-rates-and-treatment-insights\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/IVIG-Parvovirus.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/IVIG-Parvovirus.jpg","width":1280,"height":853,"caption":"Nurse preparing patient for IVIG for Parvovirus B19-Induced Pure Red Cell Aplasia"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-parvovirus-b19-induced-pure-red-cell-aplasia-benefits-success-rates-and-treatment-insights\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/"},{"@type":"ListItem","position":2,"name":"IVIG for Parvovirus B19-Induced Pure Red Cell Aplasia: Benefits, Success Rates, and Treatment Insights"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/es\/#website","url":"https:\/\/ameripharmaspecialty.com\/es\/","name":"Cuidado especializado AmeriPharma\u00ae","description":"Atenci\u00f3n especializada por AmeriPharma","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/es\/#organization","name":"Atenci\u00f3n especializada de Ameripharma","url":"https:\/\/ameripharmaspecialty.com\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/person\/aa941bb470287e10309b2fe7f5b15430","name":"Dra. Samantha Kaeberlein, PharmD","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/fabe5720eac93901a4790d5e25493a8cf2fdf076c21466237b10de4cc181b9d2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/fabe5720eac93901a4790d5e25493a8cf2fdf076c21466237b10de4cc181b9d2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/fabe5720eac93901a4790d5e25493a8cf2fdf076c21466237b10de4cc181b9d2?s=96&d=mm&r=g","caption":"Dr. Samantha Kaeberlein, PharmD"},"description":"La Dra. Samantha Kaeberlein, PharmD, naci\u00f3 y creci\u00f3 en Canton, Ohio. Obtuvo su t\u00edtulo en farmacia en la Universidad M\u00e9dica del Noreste de Ohio (NEOMED) en 2020. Lo m\u00e1s gratificante de su trabajo es brindar orientaci\u00f3n m\u00e9dica para que los pacientes puedan tomar decisiones informadas y completas sobre su atenci\u00f3n m\u00e9dica. Sus \u00e1reas de especializaci\u00f3n son la geriatr\u00eda y los cuidados a largo plazo. En su tiempo libre, disfruta de pasar tiempo al aire libre, leer y encontrar el mejor caf\u00e9 de Estados Unidos.","url":"https:\/\/ameripharmaspecialty.com\/es\/author\/samantha\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/IVIG-Parvovirus.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/IVIG-Parvovirus-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/IVIG-Parvovirus-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/IVIG-Parvovirus-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/IVIG-Parvovirus-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/IVIG-Parvovirus.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/IVIG-Parvovirus.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/IVIG-Parvovirus-18x12.jpg",18,12,true],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/IVIG-Parvovirus-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/IVIG-Parvovirus-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/IVIG-Parvovirus-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/IVIG-Parvovirus-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/IVIG-Parvovirus-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/IVIG-Parvovirus-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/IVIG-Parvovirus-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/IVIG-Parvovirus-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/IVIG-Parvovirus.jpg",1280,853,false]},"uagb_author_info":{"display_name":"Dr. Samantha Kaeberlein, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/samantha\/"},"uagb_comment_info":0,"uagb_excerpt":"IVIG for parvovirus B19-induced pure red cell aplasia is often considered the first-line treatment, especially in individuals with weakened immune systems. Learn about the benefits of IVIG, mechanism of action, and limitations of use.\u00a0","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/IVIG-Parvovirus.jpg",1280,853,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/IVIG-Parvovirus.jpg",1280,853,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/IVIG-Parvovirus.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/IVIG-Parvovirus-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/IVIG-Parvovirus-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/IVIG-Parvovirus-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/IVIG-Parvovirus.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/IVIG-Parvovirus.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/IVIG-Parvovirus-18x12.jpg",18,12,true],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/IVIG-Parvovirus-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/IVIG-Parvovirus-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/IVIG-Parvovirus-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/IVIG-Parvovirus-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/IVIG-Parvovirus-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/IVIG-Parvovirus-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/IVIG-Parvovirus-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/IVIG-Parvovirus-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/IVIG-Parvovirus.jpg",1280,853,false]},"rttpg_author":{"display_name":"Dr. Samantha Kaeberlein, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/samantha\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/es\/category\/ivig\/\" rel=\"category tag\">IVIG<\/a>","rttpg_excerpt":"IVIG for parvovirus B19-induced pure red cell aplasia is often considered the first-line treatment, especially in individuals with weakened immune systems. Learn about the benefits of IVIG, mechanism of action, and limitations of use.\u00a0","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/27865","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/comments?post=27865"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/27865\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media\/27866"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media?parent=27865"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/categories?post=27865"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/tags?post=27865"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}